| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 7, 2024 | May 8, 2024 | BOSTON SCIENTIFIC CORP | Director | Sell | 30.0 | -3,946 | -6.17% | ✓ | $286.9K |
| Mar 7, 2024 | Mar 11, 2024 | HOLOGIC INC | Director | Sell | 72.5 | +107 | 0.64% | ✓ | $111.6K |
| Jan 2, 2024 | Jan 4, 2024 | HOLOGIC INC | Director | Sell | 5.0 | -16,017 | -48.76% | ✓ | $1.2M |
| Sep 5, 2023 | Sep 7, 2023 | HAEMONETICS CORP | Director | Sell | 7.5 | -10,215 | -33.65% | ✓ | $895.7K |
| Aug 18, 2023 | Aug 18, 2023 | BOSTON SCIENTIFIC CORP | Director | Sell | 12.5 | -17,079 | -21.08% | ✓ | $866.6K |
| Dec 12, 2022 | Dec 14, 2022 | Keysight Technologies, Inc. | Director | Sell | 20.0 | -10,808 | -17.09% | ✗ | $602.8K |
| Feb 4, 2021 | Feb 5, 2021 | HAEMONETICS CORP | Director | Sell | 17.5 | -12,180 | -35.30% | ✗ | $1.6M |
| Mar 14, 2018 | Mar 16, 2018 | HOLOGIC INC | Director | Buy | 97.5 | +15,406 | 650.04% | ✗ | $504.4K |
| Jun 9, 2017 | Jun 13, 2017 | Keysight Technologies, Inc. | Director | Buy | 97.5 | +13,210 | 34.23% | ✗ | $499.5K |